BNP PARIBAS FINANCIAL MARKETS - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 63 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q1 2014. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2016$5,661,000
-15.0%
1,153
-14.1%
0.00%
Q3 2016$6,661,000
+68.2%
1,343
+72.6%
0.00%
Q2 2016$3,960,000
+267.0%
778
+311.6%
0.00%
Q1 2016$1,079,000
-97.2%
189
-94.9%
0.00%
Q4 2015$38,592,000
-49.8%
3,718
-10.7%
0.00%
Q3 2015$76,872,000
+148.9%
4,162
+162.3%
0.00%
Q2 2015$30,883,000
+293.9%
1,587
+255.8%
0.00%
Q1 2015$7,841,000
-50.1%
446
-64.3%
0.00%
Q3 2014$15,725,000
+11052.5%
1,249
+13777.8%
0.00%
Q2 2014$141,000
-90.7%
9
-91.6%
0.00%
Q1 2014$1,523,000
-68.0%
107
-63.9%
0.00%
Q4 2013$4,760,0002960.00%
Other shareholders
OSIRIS THERAPEUTICS INC NEW shareholders Q1 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,579,561$19,887,0002.73%
PRINCETON CAPITAL MANAGEMENT INC 35,825$451,0000.29%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 388,039$4,885,0000.18%
ELLINGTON MANAGEMENT GROUP LLC 15,700$198,0000.14%
Baker Brothers Advisors 510,606$6,429,0000.08%
Rodgers Brothers Inc. 10,400$131,0000.07%
Nine Chapters Capital Management LLC 31,800$400,0000.04%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 71,037$895,0000.02%
KILLEN GROUP INC 34,600$436,0000.02%
Freedom Investment Management, Inc. 10,591$133,0000.02%
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders